Rchr
J-GLOBAL ID:200901001223466596   Update date: Sep. 28, 2024

Ito Yuji

イトウ ユウジ | Ito Yuji
Affiliation and department:
Job title: Associate Professor
Homepage URL  (1): http://www.sci.kagoshima-u.ac.jp/~yito/
Research field  (4): Pharmaceuticals - chemistry and drug development ,  Pharmacology ,  Pharmaceuticals - health and biochemistry ,  Applied biofunctional and bioprocess engineering
Research keywords  (10): ファージディスプレイ ,  蛋白質工学 ,  遺伝子工学 ,  抗体 ,  ペプチド ,  Phage display ,  Protein Engineering ,  Gene Engineering ,  Therapeutic Antibody ,  Peptide
Research theme for competitive and other funds  (42):
  • 2016 - 2020 Development of artificial antibody of anti-bitter taste receptor using random amino acid sequence library
  • 2016 - 2019 Development of antibody delivery system by ultrasound responsive nano bubble and breast cancer treatment strategy
  • 2016 - 2018 Development of animal models for anti-neurofascin 155 antibody-positive inflammatory demyelinating diseases by single chain antibodies
  • 2014 - 2017 Research on the treatment of esophageal cancer with anti-human fibroblast growth factor receptor like-1
  • 2013 - 2016 Immunotherapy for ATL using specific chimeric antigen receptor
Show all
Papers (98):
  • Kyohei Muguruma, Akane Fukuda, Hayate Shida, Akihiro Taguchi, Kentaro Takayama, Atsuhiko Taniguchi, Yuji Ito, Yoshio Hayashi. Structure Derivatization of IgG-Binding Peptides and Analysis of Their Secondary Structure by Circular Dichroism Spectroscopy. Chemical & pharmaceutical bulletin. 2024. 72. 9. 831-837
  • Abdur Rafique, Genki Hichiwa, Muhammad Feisal Jatnika, Yuji Ito. A Novel Strategy for Screening Tumor-Specific Variable Domain of Heavy-Chain Antibodies. International Journal of Molecular Sciences. 2023. 24. 13. 10804-10804
  • Tomonari Matsuda, Yoko Akazawa-Ogawa, Lilian-Kaede Komaba, Norihiko Kiyose, Nobuo Miyazaki, Yusaku Mizuguchi, Tetsuo Fukuta, Yuji Ito, Yoshihisa Hagihara. Prediction of antigen-responding VHH antibodies by tracking the evolution of antibody along the time course of immunization. Frontiers in immunology. 2023. 14. 1335462-1335462
  • Narutoshi Tsukahara, Akikazu Murakami, Maiko Motohashi, Hiroshi Nakayama, Yoshiro Kondo, Yuji Ito, Takachika Azuma, Hidehiro Kishimoto. An alpaca single-domain antibody (VHH) phage-display library constructed by CDR shuffling provided high affinity VHHs against desired protein antigens. International immunology. 2022
  • Kyohei Muguruma, Rento Osawa, Akane Fukuda, Naoto Ishikawa, Konomi Fujita, Akihiro Taguchi, Kentaro Takayama, Atsuhiko Taniguchi, Yuji Ito, Yoshio Hayashi. Development of a High-Affinity Antibody-Binding Peptide for Site-Specific Modification. ChemMedChem. 2021. 16. 11. 1813-1820
more...
MISC (287):
more...
Patents (17):
Books (1):
  • 抗体医薬の最前線 第2章 ファージディスプレイによる抗体医薬開発
    シーエムシー出版 2007
Lectures and oral presentations  (60):
  • 乳癌細胞において内在化するラミニンα5鎖受容体CD239に対する抗体-薬物結合体の作製
    (日本結合組織学会学術大会抄録集 2018)
  • 効率的な抗体薬物複合体調製に向けた抗体Fc部位結合ペプチドの初期的構造活性相関研究
    (創薬懇話会講演要旨集 2018)
  • 抗体ファージライブラリからガン特異的なVHH抗体の効率的単離手法の確立
    (日本蛋白質科学会年会プログラム・要旨集 2018)
  • 抗体Fc部結合ペプチドの構造活性相関研究
    (日本薬学会年会要旨集(CD-ROM) 2018)
  • 抗体薬物複合体への適用を指向した抗体結合ペプチドの構造活性相関研究
    (日本薬学会年会要旨集(CD-ROM) 2018)
more...
Works (1):
  • 植物繊維と分解する遺伝子細換え酵母
    1997 - 1999
Education (4):
  • 1985 - 1990 Kyushu University Graduagte School of Pharmaceutical Sciences
  • - 1990 Kyushu University Graduate School, Division of Pharmaceutical Sciences
  • 1981 - 1985 Kyushu University Faculty of Pharmaceutical Sciences
  • - 1985 Kyushu University Faculty of Pharmaceutical Science
Professional career (1):
  • (BLANK)
Work history (4):
  • 2010/04 - 現在 Kagoshima University Graduagte School of Science and Engineering Professor
  • 1997/04 - 2010/04 Kagoshima University Faculty of Engineering
  • 1990/04 - 1997/03 Kyushu University School of Pharmaceutical Sciences
  • 1990 - 1997 Kyushu University, Assistant Professor
Association Membership(s) (6):
ペプチド学会 ,  生物工学会 ,  蛋白科学会 ,  生化学会 ,  免疫学会 ,  薬学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page